如何管理肠球菌菌血症患者
本文综述了肠球菌菌血症(EB)的流行病学、临床和微生物学特征及预后因素,诊断流程(包括超声心动图排除心内膜炎),抗生素管理(尤其关注耐药和复杂性EB),以及感染科会诊和集束化治疗的作用。EB发病率和死亡率负担大,多见于脆弱和免疫抑制患者,以粪肠球菌为主,其次为屎肠球菌。快速识别高危患者、早期预警系统和快速诊断技术(如MALDI-TOF联合感染科会诊和集束化治疗)可能改善管理和预后。
要点
- EB常见于院内感染,以粪肠球菌为主,其次为屎肠球菌,常为多种微生物菌血症。
- 快速识别高危患者对及时诊断和经验性治疗至关重要。
- 超声心动图在EB检查中关键,但确切指征仍有争议。
核心结论
- EB与大量发病率和死亡率相关,尤其在脆弱和免疫抑制的复杂性菌血症患者中。
研究设计与样本
- 综述,检索Pubmed从建库至2020年5月31日的文献。
主要发现
- 大多数EB由粪肠球菌引起,其次为屎肠球菌。
- EB常表现为多种微生物菌血症。
- 快速识别高危患者对及时应用诊断技术和经验性治疗至关重要。
- 早期预警系统和快速诊断技术如MALDI-TOF,尤其与感染科会诊和集束化治疗结合,可能改善管理和预后。
临床怎么用
- 应快速识别EB高危患者以及时进行诊断和治疗。
- 考虑使用早期预警系统和快速诊断技术如MALDI-TOF。
- 超声心动图应更广泛用于EB检查,尽管指征仍有争议。
- 建议采用多学科方法管理EB。
局限性
- EB管理的当前证据存在主要 gaps。
- 超声心动图在EB中的确切指征仍有争议。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Enterococcal bacteraemia (EB) is common, particularly in the nosocomial setting, and its management poses a challenge for clinicians and microbiologists. OBJECTIVES: The aim was to summarize the more relevant features of EB and to provide a practical state-of-the-art on the topics that more directly affect its management. SOURCES: Pubmed articles from inception to 31 May 2020. CONTENT: The following topics are covered: epidemiological, clinical and microbiological characteristics and factors associated with prognosis of EB; diagnosis and work-up, including the use of echocardiography to rule out endocarditis; antibiotic management with special focus on antimicrobial resistance and complicated EB; and the role of infectious disease consultation and the use of bundles in EB. In addition, three clinical vignettes are presented to illustrate the practical application of the guidance provided, and major gaps in the current evidence supporting EB management are discussed. IMPLICATIONS: EB is associated with large burdens of morbidity and mortality, particularly among fragile and immunosuppressed patients presenting complicated bacteraemia due to multidrug-resistant enterococci. Most cases of EB are caused by Enterococcus faecalis, followed by E. faecium. EB often presents as polymicrobial bacteraemia. Rapidly identifying patients at risk of EB is crucial for timely application of diagnostic techniques and empiric therapy. Early alert systems and rapid diagnostic techniques, such as matrix-assisted desorption ionization-time of flight mass spectrometry, especially if used together with infectious disease consultation within bundles, appear to improve management and prognosis of EB. Echocardiography is also key in the work-up of EB and should probably be more extensively used, although its exact indications in EB are still debated. Multidisciplinary approaches are warranted due to the complexity and severity of EB.
引用
- Rosselli Del Turco E, Bartoletti M, Dahl A, et al. How do I manage a patient with enterococcal bacteraemia? Clin Microbiol Infect. 2020. PMID: 33152537. doi:10.1016/j.cmi.2020.10.029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。